EUVIMEDEUVIMED entdecken
Crossref

SHCBP1 promotes cisplatin resistance of ovarian cancer through AKT/mTOR/Autophagy pathway

Gonghua Qi, Hanlin Ma, Kai Teng, Panpan Gai, Yanmin Gong, Jingying Chen, Xia Luo, Beihua Kong

Apoptosis · 2025

DOI: 10.1007/s10495-024-02027-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Apoptosis, 2025. Verfasst von Gonghua Qi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Qilu Hospital, Shandong University, 107 Wenhua Xi Road, Jinan, 250012, China. Hauptthemen laut MEDLINE: Cisplatin, Drug Resistance, Neoplasm, Ovarian Neoplasms, TOR Serine-Threonine Kinases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Nature Science Foundation of Shandong Province, the Tai-Shan Scholar Program from Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinDrug Resistance, NeoplasmOvarian NeoplasmsTOR Serine-Threonine KinasesAutophagyProto-Oncogene Proteins c-aktShc Signaling Adaptor ProteinsFemaleHumansCell Line, TumorAnimalsSignal TransductionCell ProliferationAntineoplastic AgentsMiceMice, NudeGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

AKT/mTORAutophagyCisplatin sensitivityOvarian cancerSHCBP1

Substanzen

CisplatinTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktMTOR protein, humanSHCBP1 protein, humanAntineoplastic AgentsShc Signaling Adaptor Proteins

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Qilu Hospital, Shandong University, 107 Wenhua Xi Road, Jinan, 250012, China.
  • Gynecologic Oncology Key Laboratory of Shandong Province, Qilu Hospital, Shandong University, Jinan, 250012, China.
  • Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong Province, 250117, China.
  • 71217 of the Chinese People's Liberation Army, Laiyang, 265200, China.
  • Department of Obstetrics and Gynecology, Qilu Hospital, Shandong University, 107 Wenhua Xi Road, Jinan, 250012, China. luoxia@email.sdu.edu.cn.
  • Department of Obstetrics and Gynecology, Qilu Hospital, Shandong University, 107 Wenhua Xi Road, Jinan, 250012, China. kongbeihua@sdu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Nature Science Foundation of Shandong Province
  • the Tai-Shan Scholar Program from Shandong Province
  • the Tai‐Shan Scholar Program from Shandong Province

Zitieren

APA

Qi, G., Ma, H., Teng, K., Gai, P., Gong, Y., Chen, J., Luo, X., & Kong, B. (2025). SHCBP1 promotes cisplatin resistance of ovarian cancer through AKT/mTOR/Autophagy pathway. Apoptosis. https://doi.org/10.1007/s10495-024-02027-3

Vancouver

Qi G, Ma H, Teng K, Gai P, Gong Y, Chen J, et al. SHCBP1 promotes cisplatin resistance of ovarian cancer through AKT/mTOR/Autophagy pathway. Apoptosis. 2025. doi:10.1007/s10495-024-02027-3

BibTeX
@article{Qi2025,
  author = {Qi, Gonghua and Ma, Hanlin and Teng, Kai and Gai, Panpan and Gong, Yanmin and Chen, Jingying and Luo, Xia and Kong, Beihua},
  title = {SHCBP1 promotes cisplatin resistance of ovarian cancer through AKT/mTOR/Autophagy pathway},
  journal = {Apoptosis},
  year = {2025},
  doi = {10.1007/s10495-024-02027-3}
}
Kostenlos starten →